SIREN : 481441939
SOCIMED is a French company founded 21 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in OSNY (95520), this company of category PME shows in 2019 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | 3 319 668 € | 2 790 432 € | 2 400 227 € | 2 084 179 € |
| Net income | 11 544 € | 149 083 € | 147 307 € | 75 880 € | 54 533 € | 36 117 € | 26 287 € | 21 872 € |
| EBITDA | N/C | N/C | N/C | N/C | 88 940 € | 112 340 € | 96 496 € | 51 563 € |
| Net margin | N/C | N/C | N/C | N/C | 1.6% | 1.3% | 1.1% | 1.0% |
In 2024, SOCIMED generates positive net income of 12 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 22 k€ -> 12 k€.
11 544 €
The debt ratio (= Financial debt / Equity x 100) stands at 74%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
74.441%
30.114%
69.4%
In 2024, the debt ratio of SOCIMED (74.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of SOCIMED (30.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 205.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
205.96
In 2024, the liquidity ratio of SOCIMED (205.96) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 124 transactions of similar company sales (all years), the value of SOCIMED is estimated at 9 483 € (range 3 609€ - 34 632€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SOCIMED with other companies in the same sector:
The revenue of SOCIMED in 2019 is 3.3 M€.
Yes, SOCIMED generated a net profit of 12 k€ in 2024.
The headquarters of SOCIMED is located in OSNY (95520), in the department Val-d'Oise.
The tax return of SOCIMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SOCIMED operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.